|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/00 | |
| A61P 35/00 |
| (11) | Patento numeris | 3065770 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14803277.4 |
| Europos patento paraiškos padavimo data | 2014-10-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-09-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-10-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/063516 |
| Data | 2014-10-31 |
| (87) | Numeris | WO 2015/069571 |
| Data | 2015-05-14 |
| (30) | Numeris | Data | Šalis |
| 201361900226 P | 2013-11-05 | US |
| (72) |
ROUNTREE, Ryan, US
FOY, Susan, US
MANDL, Stefanie, US
DELCAYRE, Alain, US
|
| (73) |
Bavarian Nordic A/S,
Hejreskovvej 10A, 3490 Kvistgaard,
DK
|
| (54) | COMBINATION THERAPY FOR TREATING CANCER WITH A POXVIRUS EXPRESSING A TUMOR ANTIGEN AND AN ANTAGONIST OF AN IMMUNE CHECKPOINT INHIBITOR |
| COMBINATION THERAPY FOR TREATING CANCER WITH A POXVIRUS EXPRESSING A TUMOR ANTIGEN AND AN ANTAGONIST OF AN IMMUNE CHECKPOINT INHIBITOR |